These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2571786)

  • 41. The relationship between body weight and tolerance to mefloquine prophylaxis in non-immune adults: results of a questionnaire-based study.
    Ollivier L; Tifratene K; Josse R; Keundjian A; Boutin JP
    Ann Trop Med Parasitol; 2004 Sep; 98(6):639-41. PubMed ID: 15324471
    [No Abstract]   [Full Text] [Related]  

  • 42. Side effects of and compliance with malaria prophylaxis in children.
    Albright TA; Binns HJ; Katz BZ
    J Travel Med; 2002; 9(6):289-92. PubMed ID: 12962582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Malaria, mefloquine and the mind.
    Ingram RJ; Ellis-Pegler RB
    N Z Med J; 1997 Apr; 110(1042):137-8. PubMed ID: 9152353
    [No Abstract]   [Full Text] [Related]  

  • 44. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
    Wolters BA; Bosje T; Luinstra-Passchier MJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):331-4. PubMed ID: 9132607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malaria chemoprophylaxis with mefloquine.
    Björkman A; Steffen R; Armengaud M; Picot N; Piccoli S
    Lancet; 1991 Jun; 337(8755):1479-80. PubMed ID: 1675342
    [No Abstract]   [Full Text] [Related]  

  • 46. Mefloquine to prevent malaria: a systematic review of trials.
    Croft A; Garner P
    BMJ; 1997 Nov; 315(7120):1412-6. PubMed ID: 9418088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolonged visual illusions induced by mefloquine (Lariam): a case report.
    Borruat FX; Nater B; Robyn L; Genton B
    J Travel Med; 2001; 8(3):148-9. PubMed ID: 11468119
    [No Abstract]   [Full Text] [Related]  

  • 48. Chemoprophylaxis according to the guidelines on malaria prevention for Japanese overseas travelers.
    Mizuno Y; Kudo K; Kano S
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():11-4. PubMed ID: 17547042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malaria prophylaxis.
    Thomas JE
    Cent Afr J Med; 1991 Oct; 37(10):339-40. PubMed ID: 1813130
    [No Abstract]   [Full Text] [Related]  

  • 50. Mefloquine for malarial prophylaxis in military personnel.
    Gogtay NJ; Ferner RE
    BMJ; 2015 Nov; 351():h5797. PubMed ID: 26534919
    [No Abstract]   [Full Text] [Related]  

  • 51. [Recurrent psychiatric manifestations during malaria prevention with mefloquine. A case report].
    Rodor F; Bianchi G; Grignon S; Samuelian JC; Jouglard J
    Therapie; 1990; 45(5):433-4. PubMed ID: 2260038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Encephalopathy and memory disorders during treatments with mefloquine].
    Marsepoil T; Petithory J; Faucher JM; Ho P; Viriot E; Benaiche F
    Rev Med Interne; 1993; 14(8):788-91. PubMed ID: 8191092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mefloquine for preventing malaria in nonimmune adult travelers.
    Cayley WE
    Am Fam Physician; 2004 Feb; 69(3):521-2. PubMed ID: 14971832
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cerebral spasm during malaria prophylaxis with mefloquine].
    Ries S
    Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1911-2. PubMed ID: 8287786
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuropsychiatric events during prophylactic use of mefloquine before travelling.
    van Riemsdijk MM; Ditters JM; Sturkenboom MC; Tulen JH; Ligthelm RJ; Overbosch D; Stricker BH
    Eur J Clin Pharmacol; 2002 Sep; 58(6):441-5. PubMed ID: 12242605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mefloquine: contraindicated in patients with mood, psychotic or seizure disorders.
    Wooltorton E
    CMAJ; 2002 Nov; 167(10):1147. PubMed ID: 12427708
    [No Abstract]   [Full Text] [Related]  

  • 57. [There is no evidence of more symptoms with mefloquine than with other drugs in malaria prophylaxis].
    Cobelens FG; van Thiel PP
    Ned Tijdschr Geneeskd; 1997 Apr; 141(16):794-5; author reply 796. PubMed ID: 9213805
    [No Abstract]   [Full Text] [Related]  

  • 58. Malaria prophylaxis. Toxicity of mefloquine is similar to that of other chemoprophylaxis.
    Croft A
    BMJ; 1995 Jul; 311(6998):191; author reply 192. PubMed ID: 7677878
    [No Abstract]   [Full Text] [Related]  

  • 59. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers.
    Petersen E; Ronne T; Ronn A; Bygbjerg I; Larsen SO
    J Travel Med; 2000; 7(2):79-84. PubMed ID: 10759574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maculopathy associated with mefloquine (Lariam) therapy for malaria prophylaxis.
    Walker RA; Colleaux KM
    Can J Ophthalmol; 2007 Feb; 42(1):125-6. PubMed ID: 17361254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.